Peripheral Nerve Repair Devices Market

Peripheral Nerve Repair Devices Market by Product Type (Nerve Conduits, Nerve Protectors, Nerve Grafts, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of chronic disorders and the increasing cases of lifestyle disorders worldwide

The peripheral nerve repair devices market is projected to grow at a 10.76% CAGR during the forecast period from 2024 to 2030. The peripheral nerve repair devices market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), cancers, increasing number of lifestyle disorders such as diabetes are expected to escalate the overall growth of the peripheral nerve repair devices market during the forecast period from 2024 to 2030.

Peripheral Nerve Repair Devices Market Dynamics:

As per recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Also, the recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally. According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people were living with CAD around the world.

Data provided by the World Health Organization (WHO) in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer globally.

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases

According to data from the International Diabetes Federation (2022), in 2021, 537 million adults aged 20 to 79 were living with diabetes, equating to about 1 in 10 individuals. This number is expected to increase to 643 million by 2030 and reach 783 million by 2045. Notably, over 75% of adults with diabetes reside in low- and middle-income countries. Additionally, 541 million adults have Impaired Glucose Tolerance (IGT), putting them at elevated risk for developing type 2 diabetes.

Peripheral nerve repair devices are used in treating conditions associated with cardiovascular diseases, cancer, and diabetes primarily for managing complications like nerve damage or neuropathy. In cardiovascular care, they may assist with nerve injuries from procedures or disease complications. In cancer treatment, they help repair nerves affected by tumors or surgical interventions. For diabetes, they address diabetic neuropathy, which is common in patients with long-term glucose management issues.

Therefore, the factors stated above collectively will drive the overall peripheral nerve repair devices market growth.

However, biocompatibility issues and risk of infection, availability of alternatives such as autografts and electrical stimulation, among others may prove to be challenging factors for peripheral nerve repair devices market growth.

Peripheral Nerve Repair Devices Market Segment Analysis:

Peripheral Nerve Repair Devices Market by Product Type (Nerve Conduits, Nerve Protectors, Nerve Grafts, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the peripheral nerve repair devices market, the nerve conduits category is expected to have a significant revenue share in the year 2023. This can be ascribed to their advantageous properties such as biodegradability, biocompatibility, and high porosity, flexibility among other features which offer better neuro conductivity and neuro inductivity than other product types.

Additionally, the development of nerve conduits in different designs such as fibrous and tubular shapes, use of different materials such as biomaterials also help address the limitations presented by allografts, xenografts, and autografts. Furthermore, it had been observed that nerve conduits offer trophic support to nerve stumps and also prevent the growth of the surrounding tissues in the gaps between the stumps. They also promote nerve regeneration by providing a supportive microenvironment for axonal growth thereby providing better outcomes in events of peripheral nerve damage or injury.

Therefore the widespread uses and various advantages of nerve conduits enhance performance and usability, solidifying the significant impact on the growth of the overall peripheral nerve repair devicess market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall peripheral nerve repair devices market:

Among all the regions, North America is expected to dominate the peripheral nerve repair devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This can be attributed to several factors including the rising incidence of chronic conditions like diabetes, increased focus on product development and regulatory approvals, and the growing demand for advanced treatment options, which are acting as key factors contributing to the growth of the peripheral nerve repair devices market in the North America region during the forecast period from 2024 to 2030.

According to data from the Centers for Disease Control and Prevention (2024), stated that in 2021, in the US, 38.4 million people of all ages, or 11.6% of the population, were affected by diabetes. Among adults aged 18 years and older, 38.1 million, or 14.7%, were affected by the condition. Additionally, 8.7 million adults aged 18 and older who meet the laboratory criteria for diabetes are either unaware or do not report having the disease. This represents 3.4% of all U.S. adults and 22.8% of adults with diabetes. The prevalence of diabetes among adults increases with age, reaching 29.2% in those aged 65 years and older. As per data from the Public Health Agency of Canada 2024, it states that 3.7 million were living with diagnosed diabetes in 2021.

Peripheral nerve repair devices are used to address complications arising from diabetes, a condition that often leads to chronic nerve damage, particularly in severe cases. For individuals with diabetes, nerve damage can cause significant pain, numbness, and loss of function in the extremities. These devices aid in repairing damaged nerves and improving function, which is crucial for managing symptoms and enhancing quality of life. In the context of diabetes, such devices are especially important as the condition frequently leads to progressive and debilitating nerve damage, making effective repair and management strategies essential for patient care.

Rising product developmental activities by regulatory bodies in the region will further boost the market for peripheral nerve repair devices. For example, In December 2023, Alafair Biosciences received FDA 510(k) clearance for its VersaWrap device. The clearance permitted pediatric surgeons and medical facilities to treat younger patients with the VersaWrap Class II medical device. The US FDA approval allowed the application of the bioresorbable hydrogel implant across all patient populations, regardless of age. VersaWrap created a gelatinous coating around target tissues such as tendons, peripheral nerves, and surrounding soft tissues.

In addition to this, in November 2023, Medtronic launched a new frontier in treating high blood pressure as the FDA-approved medical device-related hypertension therapy in the U.S. For the first time, there were approved medical device-related procedures to treat Americans with hypertension (high blood pressure). The U.S. Food and Drug Administration (FDA) approved the Medtronic Symplicity Spyral™ renal denervation system for use in the United States. The system, which carried the FDA’s Breakthrough Device designation, used radio frequency to disrupt overactive nerves in the kidneys and help lower blood pressure.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American peripheral nerve repair devices market.

Peripheral Nerve Repair Devices Market key players:

Some of the key market players operating in the peripheral nerve repair devices market include Integra LifeSciences, Axogen Inc., Medovent GmbH, Synovis Micro Companies Alliance, Inc., Stryker, Toyobo Co. Ltd., Polyganics BV, Collagen Matrix Inc., Neuroregen L.C.C., Cook Biotech Products, and others.

Recent Developmental Activities in the Peripheral Nerve Repair Devices Market:

• In September 2025, Tissium, a Paris-based company, received FDA De Novo clearance for its non-traumatic peripheral nerve repair platform, enabling commercialization of its first product—a blue light-activated, biocompatible polymer shown to restore full finger movement without pain in clinical trials.
• In June 2025, 3D Systems (NYSE: DDD) announced that its 3D bioprinting technologies have enabled FDA approval for regenerative repair of peripheral nerve damage. This milestone was achieved through a partnership with TISSIUM, a French MedTech pioneer in biomorphic programmable polymers for tissue reconstruction. The collaboration combined TISSIUM’s proprietary polymers with 3D Systems’ bioprinting expertise to develop a fully bioabsorbable 3D-printed medical device using a unique photopolymer for nerve repair.
• In June 2025, the FDA granted De Novo marketing authorization to TISSIUM’s COAPTIUM® CONNECT with TISSIUM Light, the first FDA-approved atraumatic sutureless system for peripheral nerve repair, enabling U.S. commercialization.
• In September 2024, Neuraptive Therapeutics, Inc. announced that NTX-001 has been granted Breakthrough Therapy Designation, paving the way for accelerated development for patients with peripheral nerve injury requiring repair. This designation comes after promising results from the Phase 2 NEUROFUSE study and multiple interactions with the FDA. NTX-001 holds the potential to be a groundbreaking therapy in the nerve repair field.
• In September 2023, Axogen announced that it had fully launched its Axoguard HA+ nerve protector for peripheral nerve injury protection. The company designed the proprietary device to provide both short- and long-term protection for nerve injuries. It featured a processed porcine submucosa extracellular matrix base layer with a hyaluronate-alginate gel coating.
• In April 2023, Amend Surgical, Inc, an Alachua-based medical device company, was awarded substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the repair of peripheral nerves. Tissure, a resorbable hydrogel membrane with a chitosan-based adhesive, possessed the adhesion and mechanical strength to potentially replace sutures for the repair of peripheral nerve injuries.
• In July 2022, Checkpoint Surgical announced the launch of the Checkpoint Edge™ Nerve Cutting Kit, extending the breadth of the company's intraoperative nerve care portfolio. The Checkpoint Edge Nerve Cutting Kit was the first offering in Checkpoint Surgical's planned portfolio of nerve-specific instruments, with further expansion anticipated in the following months.

Key Takeaways from the Peripheral Nerve Repair Devices Market Report Study

• Market size analysis for current peripheral nerve repair devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the peripheral nerve repair devices market.
• Various opportunities available for the other competitors in the Peripheral Nerve Repair Devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current peripheral nerve repair devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Peripheral nerve repair devices market growth in the coming future?

Target Audience who can be benefited from this Peripheral Nerve Repair Devices Market Report Study

• Peripheral nerve repair devices product providers
• Research organizations and consulting companies
• Peripheral nerve repair devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in peripheral nerve repair devices
• Various end-users who want to know more about the peripheral nerve repair devices market and the latest technological developments in the peripheral nerve repair devices market